XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Equity (Tables)
 6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
Equity
 
Three Months Ended June 30,
 
  
Common Stock
Other
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
 
Treasury Stock
Non-
Controlling
Interests
Total
($ and shares in millions except per share amounts)
Shares
Par Value
Shares
Cost
Balance at April 1, 2018
3,577

$
1,788

$
39,874

$
41,107

$
(5,060
)
885

$
(44,041
)
$
233

$
33,901

Net income attributable to Merck & Co., Inc.
—

—

—

1,707

—

—

—

—

1,707

Other comprehensive loss, net of taxes
—

—

—

—

(62
)
—

—

—

(62
)
Cash dividends declared on common stock ($0.48 per share)
—

—

—

(1,291
)
—

—

—

—

(1,291
)
Treasury stock shares purchased
—

—

—

—

—

27

(1,596
)
—

(1,596
)
Share-based compensation plans and other
—

—

(133
)
—

—

(5
)
236

—

103

Net income attributable to noncontrolling interests
—

—

—

—

—

—

—

9

9

Distributions attributable to noncontrolling interests
—

—

—

—

—

—

—

(5
)
(5
)
Balance at June 30, 2018
3,577

$
1,788

$
39,741

$
41,523

$
(5,122
)
907

$
(45,401
)
$
237

$
32,766

Balance at April 1, 2019
3,577

$
1,788

$
38,768

$
44,065

$
(5,346
)
994

$
(51,736
)
$
131

$
27,670

Net income attributable to Merck & Co., Inc.
—

—

—

2,670

—

—

—

—

2,670

Other comprehensive loss, net of taxes
—

—

—

—

(16
)
—

—

—

(16
)
Cash dividends declared on common stock ($0.55 per share)
—

—

—

(1,440
)
—

—

—

—

(1,440
)
Treasury stock shares purchased
—

—

1,000

—

—

24

(2,235
)
—

(1,235
)
Share-based compensation plans and other
—

—

(284
)
—

—

(8
)
401

—

117

Net loss attributable to noncontrolling interests
—

—

—

—

—

—

—

(26
)
(26
)
Other changes in noncontrolling ownership interests
—

—

—

—

—

—

—

(3
)
(3
)
Balance at June 30, 2019
3,577

$
1,788

$
39,484

$
45,295

$
(5,362
)
1,010

$
(53,570
)
$
102

$
27,737

 
Six Months Ended June 30,
 
  
Common Stock
Other
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
 
Treasury Stock
Non-
Controlling
Interests
Total
($ and shares in millions except per share amounts)
Shares
Par Value
Shares
Cost
Balance at January 1, 2018
3,577

$
1,788

$
39,902

$
41,350

$
(4,910
)
880

$
(43,794
)
$
233

$
34,569

Net income attributable to Merck & Co., Inc.
—

—

—

2,443

—

—

—

—

2,443

Adoption of new accounting standards
—

—

—

322

(274
)
—

—

—

48

Other comprehensive income, net of taxes
—

—

—

—

62

—

—

—

62

Cash dividends declared on common stock ($0.96 per share)
—

—

—

(2,592
)
—

—

—

—

(2,592
)
Treasury stock shares purchased
—

—

—

—

—

37

(2,162
)
—

(2,162
)
Share-based compensation plans and other
—

—

(161
)
—

—

(10
)
555

—

394

Net income attributable to noncontrolling interests
—

—

—

—

—

—

—

14

14

Distributions attributable to noncontrolling interests
—

—

—

—

—

—

—

(10
)
(10
)
Balance at June 30, 2018
3,577

$
1,788

$
39,741

$
41,523

$
(5,122
)
907

$
(45,401
)
$
237

$
32,766

Balance at January 1, 2019
3,577

$
1,788

$
38,808

$
42,579

$
(5,545
)
985

$
(50,929
)
$
181

$
26,882

Net income attributable to Merck & Co., Inc.
—

—

—

5,585

—

—

—

—

5,585

Other comprehensive income, net of taxes
—

—

—

—

183

—

—

—

183

Cash dividends declared on common stock ($1.10 per share)
—

—

—

(2,869
)
—

—

—

—

(2,869
)
Treasury stock shares purchased
—

—

1,000

—

—

38

(3,325
)
—

(2,325
)
Share-based compensation plans and other
—

—

(324
)
—

—

(13
)
684

—

360

Net loss attributable to noncontrolling interests
—

—

—

—

—

—

—

(79
)
(79
)
Balance at June 30, 2019
3,577

$
1,788

$
39,484

$
45,295

$
(5,362
)
1,010

$
(53,570
)
$
102

$
27,737